News

The new plant will include 8,000 liters of production capacity, a complete purification installation, and ample room for additional future capacity expansions. Commercial approvals for the new site

TransferCenter version 2.1 also features a fresh user interface for easier navigation, specific protocols by case type to help transfer personnel reduce errors, and aids to make data

PharmaVigilant claims that the I-Warehouse 3.0 offers immediate and ubiquitous access to study data with comparable results. I-Warehouse offers search criteria and a more streamlined selection process with

A positive opinion by the COMP immediately precedes official designation of darinaparsin as an orphan drug by the European Commission (EC). Ziopharm expects to commence a registration-directed study

Clinical trials of Ceplene showed that it prolongs remission and prevents relapse in patients under the age 60, and it was also successful in averting additional 20% of

The model will be used to get a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight

The acquisition is expected to create in the UK a major primary care medical property and pharmacy group with property assets of £504m. Assura has also entered into

Under the licensing agreement, Cellectis can use all technology of the university related to any field. The technology has shown positive results in genome engineering and is complementary

GSK2402968, an antisense oligonucleotide which induces exon skipping of exon 51, is currently in late stage development for DMD. The study which is designed to evaluate the safety